바로가기 메뉴
컨텐츠바로가기
주메뉴바로가기
하단메뉴바로가기

Market Report

Market Report

WOUND DRESSING MARKET IN KOREA 2019
2019.0986 pagesID: 20190001Format: PDF

Copyright© 2019 Synex Consulting Ltd., All rights reserved.

In 2018, wound dressing purchase from medical institutions is estimated to have reached approximately US$*** million, which is the sum of reimbursement products, US$*** million and non-reimbursement products US$*** million. The market size grew ***% over three years from about US$*** million in 2016. In addition, the there is an increase of ***% YoY in 2017, purchase price of In addition, the company increased ***% YoY and total purchase price of US$*** million. Therefore, reimbursement expansion of national health insurance has contributed the rapid growth of this market.

In 2018, among National Health Insurance wound dressing claim amount of US$*** million from medical institutions, it is segmented as following: foam dressing US$*** million (***%), NPWT US$*** million (***%), hydrocolloid US$*** million (***%), film US$*** million (***%), synthetic gauze US$*** million, alginate/hydrofiber US$*** million.

There are total *** of advanced wound dressing distributors who are manufacturers and/or importers who have listed approximately *** types of products (based on the product code listed on the ``Therapeutic products Reimbursement / Non-Reimbursement List and Maximum Cap Price Table''. Among these, the top *** companies market share is approximately ***% of the total market and about *** companies supplied rest of ***%. Based on the upper limit of health insurance treatment products of wound dressing market purchase price and market share of top *** companies(non-reimbursement products are based on medical institution purchase price), it is composed of following: Molnycke US$*** million, Smith&Nephew US$*** million, Mundi Pharma US$*** million, US$*** million Juthis, and US$*** million Ildong.

In 2018, total cost of wound dressing by medical department are composed of following: US$*** million of surgery (***%), US$*** million of internal medicine (***%), US$*** million of orthopedics (***%) followed by US$*** million of plastic surgery (***%)

In 2018, total cost of wound dressing by end users are composed of following: US$*** of tertiary hospital, and it has the largest segment of ***% among wound dressing Claim Amount , followed by US$*** million of general hospital (***%) and US$*** million of hospital (***%).

For the next five years, with at least ***% annual growth rate, the medical institution purchase price of wound dressing market in Korea is expected to grow US$ *** million by 2023. The sustained growth of the wound dressings market is due to all the major factors that have a significant impact on the demand for wound care. Rapid aging, a steady increase in the number of surgeries, an increase in the wound care demand, an increase in the diabetic population, an increase in pressure sores, burns, and cosmetic surgery will drive the continuous growth of this market in the future.

Health insurance in Korea is both play a role as an opportunity and a threat in the wound dressing market in Korea. In the last two decades, health insurance has played a leading role in growing the wound dressing market by continuously increasing the reimbursement coverage. In the future, health insurance will be the biggest variable for the growth of wound dressings. There still is a need for products implemented with new technology that provide convenience and clinical benefit to users and patients. The employer and the patient are willing to pay extra if the product is valuable, even if it is not necessarily covered by the insurance. However, the wound dressing classification system of health insurance currently makes it very difficult for new technology products to be listed in new categories and approved for new prices. For these products, demonstrating cost-effectiveness or quality of life based on clinical evidence will be the biggest barrier to new products.

GLOSSARYOF TERMS,ABBREVIATIONS, AND ACRONYMS


CHAPTER 1. INTRODUCTION
1.1 Purpose
1.2 Utilization of Benefits
1.3 Scope
1.4 Market Segmentation
1.5 Research Methods
1.5.1 Secondary Research
1.5.2 Primary Research
1.6 Analysis and Estimation Methods
1.6.1 Market Size Price Standard by Data Source
1.6.2 Exchange Rate

CHAPTER 2. EXECUTIVE SUMMARY

CHAPTER 3. MARKET OVERVIEW
3.1 Total Market
3.1.1 5-YearForecast
3.2 Market Size by Distribution Channels
3.3 Use Volume of Wound Dressing by Medical Institutions
3.3.1 Wound Care Product Market, By Product Category
3.3.2 Market Size by Distributors
3.3.3 Wound Care Product Market, By Medical Department
3.3.4 Wound Care Product Market, By End User Type

CHAPTER 4. MAJOR SUPPLIERS STATUS
4.1 Coloplast
4.2 Convatec GroupPlc
4.3 Molnlycke Health Care AB
4.4 Mundi Pharma
4.5 Smith & Nephew PLC
4.6 Juthis
4.7 Ildong Pharmaceutical
4.8 Daewoong Pharmaceutical
4.9 KCI
4.10 3M

CHAPTER 5. MARKET DYNAMICS
5.1 Country Health care Key Indicators
5.1.1 Historical Overview and Prospect of Market Development
5.1.2 Historical Overview of Payment Environment
5.1.3 Number of Medical Institutions in Korea
5.1.4 Reimbursement and Non-Reimbursement Classifications of Wound Dressings
5.2 Recent trends in key indicators of Market Size
5.2.1 Aging Population
5.2.2 Number of Surgical Procedures
5.2.3 Number of Wound Dressing Treatments
5.2.3.1 Simple Treatment
5.2.3.2 Inflammatory Treatment
5.2.3.3 Burn Treatment
5.2.3.4 Dermatological treatment
5.2.3.5 Biological Treatment
5.2.3.6 Post-operative Treatments
5.2.4 Diabetic Foot Ulcer
5.2.5 Pressure Ulcer
5.2.6 Burns
5.2.7 Aesthetic Plastic Surgery
5.3 Market Drivers
5.3.1 Main Indicator
5.3.2 Supply
5.4 Opportunity
5.4.1 Increasing Demand due to Aging Population
5.4.2 Coverage Expansion of National Health Insurance Policy
5.4.3 Wound Dressing with Innovative Features
5.4.4 Clinical Study on New Wound Treatment Technology
5.5 Threat
5.5.1 Revaluation of Reimbursement Prices
5.5.2 Classification System of Health Insurance Policy
5.5.3 Pricing Methods for Health Insurance Policy Restraining New Tech Products
5.6 Unmet Needs
5.6.1 Novel Technology Function Wound Dressing

[Table 1] Korean Wound Dressing Market Size (unit: US$1,000)
[Table 2] Korean Wound Dressing Market Volume Forecast (2018-2023) (Unit: US$ 1,000)
[Table 3] Use Volume of Wound Dressing by Medical Institutions
[Table 4] Reimbursement by Wound Dressing Product Category (2016-2018)
[Table 5] Sales Volume Distributors (2018)
[Table 6] Wound Care Product Market, By Medical Department (2016-2018)
[Table 7] Sales Prospects by Major Departments
[Table 8] Wound Care Product Market, By End User Type (2016-2018)
[Table 9] Major Brands of Manufacturers and Suppliers
[Table 10] Product Portfolio of Major Suppliers (2019)
[Table 11] Coloplast Main Distributor Status
[Table 12] Convatec Main Distributor Status
[Table 13] Molnlycke Main Distributor Status
[Table 14] Mundipharma Main Distributor Status
[Table 15] Smith & Nephew Main Distributor Status
[Table 16] JUTHIS Main Distributor Status
[Table 17] Ildong Main Distributor Status
[Table 18] Daewoong Main Distributor Status
[Table 19] KCI Main Distributor Status
[Table 20] 3M Distributor Status
[Table 21] Number of Medical Institutions in Korea (2018)
[Table 22] Reimbursement and Non-Reimbursement Classifications of Wound Dressings
[Table 23] Korean Population and Elderly Population of Age 65 or Over
[Table 24] Number of Surgery Claims of National Health Insurance (2010-2018)
[Table 25] Annual Number of Major Surgical Procedures 2012-2017
[Table 26] National Health Insurance Wound Dressing Treatment Fee Code, Service Description and Definition
[Table 27] Health Insurance Service Wound Therapy Fee Reimbursement Performance (2014-2018)
[Table 28] Total Reimbursement Records of Wound Treatment _Simple Treatment (2014-2018)
[Table 29] Total Reimbursement Records of Wound Treatment _ Inflammatory Treatment (2014-2018)
[Table 30] Total Reimbursement Records of Wound Treatment _ Burn Treatment (2014-2018)018)
[Table 31] Total Reimbursement Records of Wound Treatment _Dermatological Treatment (2014-2018)
[Table 32] Total Reimbursement Records of Wound Treatment _ Biological Treatment (2014-2018)
[Table 33] Total Reimbursement Records of Wound Treatment _ Post-operative Treatment (2014-2018)
[Table 34] Diabetic Foot Ulcer Patients (2014-2018)
[Table 35] Number of Bedsores Treated Patients in Korean Medical Institutions (2014-2018)
[Table 36] Medical Status of Bedsores in Korean Medical Institutions by Age Group (2018)
[Table 37] Korean Medical Institutions Burn Treatment Status (2014-2018)
[Table 38] Number of Cosmetic Surgery and the Surgical Cases (2011-2015)
[Table 39] Total Number of Procedures by Country (2014)
[Table 40] Summary of Market Drivers
[Table 41] Number of Wound Dressings Listed for Reimbursement
[Table 42] Reimbursement Criteria by Wound Dressing Types
[Fig1] Wound Dressing Supply Volume in Korea (2014-2018) (unit: US$1,000)
[Fig 2] Korean Wound Dressing Market Sales Forecast (Unit: US$ 1,000)
[Fig 3] Wound Dressing Market Size by Distribution Channel (2018)
[Fig 4] Use Volume of Wound Dressing by Medical Institutions
[Fig 5] Wound Care Product Market, By Product Category (Unit: US$ 1,000) (2018)
[Fig 6] Reimbursement Size by Wound Dressing Product Category
[Fig 7] Sales Volume Distributors (2018) (US$ Million)
[Fig 8] Wound Care Product Market, By Medical Department (2018)
[Fig 9] Wound Care Product Market, By Medical Department (2016-2018)
[Fig 10] Wound Care Product Market, By End User Type (2018)
[Fig 11] Wound Care Product Market, By End User Type (2016-2018)
[Fig 12] Elderly Age 65 or Over Populations (Unit: million)
[Fig 13] Number of National Health Insurance Claims for Surgical Procedures (2010-2014)
[Fig 14] Diabetic Foot Ulcer Patients (2014-2018)
[Fig 15] Bedsores Patients in Korea (2014-2018)
[Fig 16] Burn Patients in Korea (2014-2018)
[Fig 17] Number of Cosmetic Surgery in Korea (2011-2018)

Coloplast
Convatec Group PLC
Mölnlycke Health Care AB
Mundi Pharma
Smith & Nephew PLC
Juthis
Ildong Pharmaceutical
Daewoong Pharmaceutical
KCI
3M

USD $2,500 (excluded VAT)


_